Výsledky vyhledávání - "A. M. J. Lucassen"

THU0141 Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high dose prednisolone, in early rheumatoid arthritispatients: the cobra-light trial

Autor: Pit J S M Kerstens, N. Konijn, D. van Schaardenburg, Maarten Boers, M. T. Nurmohamed, D. den Uyl, Irene E. M. Bultink, L. van Tuyl, M. J. Lucassen, M. M. ter Wee, W.F. Lems

Publikováno v: THURSDAY, 14 JUNE 2018.

Background COmbinatie therapie Bij Reumatoide Artiritis (COBRA)-light therapy (methotrexate and initially 30 mg/day prednisolone) has proven to be non-inferior to COBRA therapy (methotrexate, sulfasalazine and initially 60 mg/day prednisolone) in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8e27e91e04a22f6b6e4e5d1c47015073
https://doi.org/10.1136/annrheumdis-2018-eular.2826

Zobrazit plný text záznamu

EORTC Receptor and Biomarker Study Group report: a sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumor tissue extracts

Autor: J. R. Westphal, C.G.J. Sweep, Paul N. Span, Nicolai Grebenchtchikov, J. (Anneke) Geurts-Moespot, A. M. J. Lucassen

Publikováno v: International Journal of Biological Markers, 15, 2, pp. 184-191
ResearcherID
International Journal of Biological Markers, 15, 184-191

A four-antibody sandwich enzyme-linked immunosorbent assay (ELISA) for vascular endothelial growth factor (VEGF) for application in blood (serum and plasma) and tumor tissue extracts was set up within the framework of the EORTC Receptor and Biomarker

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43e12e3cde914ea24a549715aa7b6e6f
https://repository.ubn.ru.nl/handle/2066/265865

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání